Literature DB >> 34237446

Targeted exome sequencing identified a novel frameshift variant in the PGAM2 gene causing glycogen storage disease type X.

Anam Nayab1, Qamre Alam2, Othman R Alzahrani3, Ranjha Khan4, Sara Sarfaraz5, Alrayan Abass Albaz6, Misbahuddin M Rafeeq7, Ziaullah M Sain8, Ahmed Waqas9, Muhammad Umair10.   

Abstract

BACKGROUND: Phosphoglycerate mutase (PGAM) deficiency is associated with a rare glycogen storage disease (glycogenosis type X) in humans caused by pathogenic variants in the PGAM2 gene. Several genes causing autosomal forms of glycogen storage disease (GSD) have been identified, involved in various forms of neuromuscular anomalies.
METHODS: Targeted whole exome sequencing (WES) was performed on the DNA of single affected individual (IV-1) followed by Sanger sequencing confirmation of the identified variant in all available members of the family.
RESULTS: In the present study, the affected individual, presenting mild features of glycogen storage disease type X. Targeted exome sequencing revealed a biallelic frameshift variant (c.687dupC; p. Met230Hisfs*6) in the PGAM2 gene located on chromosome 7p13.
CONCLUSION: In short, we reported a novel homozygous frameshift variant as a cause of glycogen storage disease type X from Pakistani population. The work presented here proves significance of targeted WES in accurate diagnosis of known complex genetic disorders.
Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Frameshift variant; Glycogen storage disease type X; PGAM2 gene; Phosphoglycerate mutase; Whole exome sequencing

Year:  2021        PMID: 34237446     DOI: 10.1016/j.ejmg.2021.104283

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  1 in total

1.  Case Report: Biallelic Variant in the tRNA Methyltransferase Domain of the AlkB Homolog 8 Causes Syndromic Intellectual Disability.

Authors:  Ahmed Waqas; Anam Nayab; Shabnam Shaheen; Safdar Abbas; Muhammad Latif; Misbahuddin M Rafeeq; Ibtesam S Al-Dhuayan; Amany I Alqosaibi; Mashael M Alnamshan; Ziaullah M Sain; Alaa Hamed Habib; Qamre Alam; Muhammad Umair; Muhammad Arif Nadeem Saqib
Journal:  Front Genet       Date:  2022-04-28       Impact factor: 4.772

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.